ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock VRAYQ vs. GMVDF, SDCCQ, AHPI, NMRD, VIVE, BRSH, UTRS, MOTS, DRTSW, and ANZUWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include G Medical Innovations (GMVDF), SmileDirectClub (SDCCQ), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Viveve Medical (VIVE), Bruush Oral Care (BRSH), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry. ViewRay vs. G Medical Innovations SmileDirectClub Allied Healthcare Products Nemaura Medical Viveve Medical Bruush Oral Care Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings, community ranking and media sentiment. Which has more risk and volatility, VRAYQ or GMVDF? ViewRay has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 55.39, suggesting that its share price is 5,439% more volatile than the S&P 500. Is VRAYQ or GMVDF more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A G Medical Innovations N/A N/A N/A Does the MarketBeat Community favor VRAYQ or GMVDF? ViewRay and G Medical Innovations both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/AG Medical InnovationsN/AN/A Which has preferable valuation and earnings, VRAYQ or GMVDF? G Medical Innovations has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/AG Medical Innovations$4.42M0.01-$24.63MN/AN/A Does the media favor VRAYQ or GMVDF? In the previous week, ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score. Company Overall Sentiment ViewRay Neutral G Medical Innovations Neutral Do institutionals & insiders believe in VRAYQ or GMVDF? 15.5% of ViewRay shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 2.5% of ViewRay shares are held by insiders. Comparatively, 37.1% of G Medical Innovations shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryG Medical Innovations beats ViewRay on 3 of the 5 factors compared between the two stocks. Remove Ads Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18,000.00$3.28B$5.63B$7.84BDividend YieldN/A1.63%5.33%4.01%P/E RatioN/A14.6123.6018.74Price / SalesN/A43.25388.2390.77Price / CashN/A44.0938.1734.64Price / BookN/A3.406.894.23Net Income-$107.33M$94.03M$3.20B$247.47M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18,000.00$102.21M0.00300Gap DownGMVDFG Medical InnovationsN/A$0.00flatN/AN/A$52,000.00$4.42M0.0072SDCCQSmileDirectClubN/A$0.00-50.0%N/A-88.0%$40,000.00$470.74M0.002,700Gap DownAHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Analyst ForecastNews CoverageGap UpNMRDNemaura MedicalN/A$0.00flatN/AN/A$8,000.00$3,017.000.0040VIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070BRSHBruush Oral CareN/A$0.00flatN/AN/A$1,000.00$2.92M0.0011News CoverageUTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160MOTSMotus GIN/AN/AN/AN/A$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.23-3.5%N/A-13.6%$0.00N/A0.0080Gap DownANZUWAnzu Special Acquisition Corp IN/A$0.03+3.6%N/A-69.0%$0.00N/A0.002Gap Up Remove Ads Related Companies and Tools Related Companies G Medical Innovations Alternatives SmileDirectClub Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Viveve Medical Alternatives Bruush Oral Care Alternatives Minerva Surgical Alternatives Motus GI Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
